Salindato, Baby Boy .

HRN: 29-04-91  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2026
CEFTAZIDIME 1GM (VIAL)
06/01/2026
06/07/2026
IVT
80mg
Q12H
Neonatal Ascites
Checking Initial Appropriateness 
06/01/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/01/2026
06/07/2026
IVT
40mg
Loading Dose
Neonatal Ascites
Checking Initial Appropriateness 
06/01/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/01/2026
06/07/2026
IVT
20mg
Q8H
Neonatal Ascites
Checking Initial Appropriateness 
06/15/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/15/2026
06/28/2026
IV DRIP
300mg
Q8
Neonatal Sepsis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: